Health
|
Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.
|
Policies or Program
|
Health
|
Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
|
Policies or Program
|
Health
|
Discussion on the opioid crisis and the Health minister's expectations from pharmaceutical manufacturers
|
Policies or Program
|
Economic Development, Research and Development, Science and Technology, Taxation and Finance
|
Improvements to the supports offered by the federal government to support R&D; in particular, generic drug research and development.
|
Policies or Program
|
Health
|
Policies aimed at facilitating generic drug repurposing.
|
Policies or Program
|
Economic Development, Health, Industry
|
Policies aimed at reinforcing pharmaceutical supply chain.
|
Policies or Program
|
Economic Development, Health, Industry
|
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.
|
Grant, Contribution or Other Financial Benefit
|
